Metabolic syndrome, or What you will: definitions and epidemiology

scientific article published on March 2007

Metabolic syndrome, or What you will: definitions and epidemiology is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.3132/DVDR.2007.003
P698PubMed publication ID17469041
P5875ResearchGate publication ID6361024

P2093author name stringCaroline Day
P2860cites workAssociation of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study.Q51479700
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.Q51482560
An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus.Q51494825
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.Q51610700
Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria.Q53241303
Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women.Q53248709
Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation.Q53258018
Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the YoungQ53937437
Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort StudyQ57502538
The Impact of Central Obesity as a Prerequisite for the Diagnosis of Metabolic Syndrome*Q57502562
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Banting lecture 1988. Role of insulin resistance in human diseaseQ29547283
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationQ29547453
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyQ29614468
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionQ29615691
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementQ29619465
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesQ33989576
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndromeQ34116177
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studiesQ34574433
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.Q35135723
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goalsQ35781463
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of DiabetesQ36218262
Insulin resistance--a common link between type 2 diabetes and cardiovascular diseaseQ36458543
The insulin resistance syndrome: physiological considerationsQ36806509
Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definitionQ39734387
Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese populationQ39752727
Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither?Q40174964
Diabetes and Cardiovascular Disease: The “Common Soil” HypothesisQ40495289
Immunoassay of insulin with insulin-antibody precipitateQ42961363
Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-UpQ44187043
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.Q44470244
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring StudiesQ44527080
Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis StudyQ44779338
Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individualQ45034127
Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitionsQ45118545
Obesity, regional body fat distribution, and the metabolic syndrome in older men and womenQ46433125
Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.Q46545819
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsQ46637307
Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitionsQ46722365
Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health StudyQ46868484
Metabolic syndrome by the international diabetes federation definition in Hong Kong ChineseQ46889306
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.Q46966762
Performance of an NIDDM screening questionnaire based on symptoms and risk factors.Q50963000
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmetabolic syndromeQ657193
P304page(s)32-38
P577publication date2007-03-01
P1433published inDiabetes and Vascular Disease ResearchQ5270121
P1476titleMetabolic syndrome, or What you will: definitions and epidemiology
P478volume4

Reverse relations

cites work (P2860)
Q944647623-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome
Q34694696A comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and system
Q46507278A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy
Q37192486A novel mathematical model detecting early individual changes of insulin resistance
Q34058368Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study
Q37193640Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study
Q40067661All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population
Q34059792Analysis of multiple phenotypes
Q60046980Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
Q59126584Are non-high-density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study
Q36522670Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat
Q37105241Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study
Q90246131Association of Dietary Patterns with Metabolic Syndrome: Results from the Kardiovize Brno 2030 Study
Q42281087Association of meal frequency with metabolic syndrome in Korean adults: from the Korea National Health and Nutrition Examination Survey (KNHANES).
Q36421188Autoimmune thyroid disease in rheumatoid arthritis: a global perspective
Q33578721Behind and beyond the pediatric metabolic syndrome
Q36812792Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study
Q50104362Body Mass Index and Acute Ischemic Stroke Outcomes
Q46916215Can prolonged administration of valproic acid put patients with epilepsy at higher risk for development of Alzheimer's disease?
Q50707024Cardiometabolic risk among Saudi children and adolescents: Saudi childrens overweight, obesity, and lifestyles (S.Ch.O.O.Ls) study.
Q46296977Chronic social stress during adolescence in mice alters fat distribution in late life: prevention by antidepressant treatment
Q36241377Comparison Study of Metabolic Syndrome's Differences and Diagnostic Criteria's Applicability among Xingjiang Uighur, Kazak and Han Population
Q37626591Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population.
Q43256494Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer
Q37847244Current understanding of increased insulin sensitivity after exercise - emerging candidates.
Q47375228Di-(2-ethylhexyl)-phthalate induces glucose metabolic disorder in adolescent rats
Q27010200Diabetes, insulin resistance, and metabolic syndrome in horses
Q55404051Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs.
Q51434807Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome.
Q41616248Early developmental exposure to high fructose intake in rats with NaCl stimulation causes cardiac damage.
Q93016323Early evaluation of the metabolic syndrome in Bucaramanga, Colombia
Q37452687Effects of caloric restriction on cardiovascular aging in non-human primates and humans
Q33690934Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats
Q36986975Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial
Q30248414Epidemiology of the locomotive syndrome: The research on osteoarthritis/osteoporosis against disability study 2005-2015.
Q37078521Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell
Q34099229Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: a comparative study.
Q51580276Evaluation of anthropometric indices for metabolic syndrome in Chinese adults aged 40 years and over.
Q34627551Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population
Q36402230Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.
Q35671305GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis
Q34057144Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome
Q46352521Glycosylated hemoglobin and prevalent metabolic syndrome in nondiabetic multiethnic U.S. adults
Q37678520Gonadal dysfunction in morbidly obese adolescent girls
Q38831748Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage
Q37385840Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
Q37635741Improved insulin sensitivity after exercise: focus on insulin signaling
Q36360699Increased anxiety-like behavior is associated with the metabolic syndrome in non-stressed rats
Q51392149Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Q35912264Is the association of continuous metabolic syndrome risk score with body mass index independent of physical activity? The CASPIAN-III study.
Q85704506Liuwei Dihuang, a traditional Chinese herbal formula, suppresses chronic inflammation and oxidative stress in obese rats
Q90132767Maternal selenium status is profoundly involved in metabolic fetal programming by modulating insulin resistance, oxidative balance and energy homeostasis
Q34877796Mechanisms of developmental programming of the metabolic syndrome and related disorders
Q38132056Mediterranean diet and metabolic syndrome: an updated systematic review.
Q37198401Menstrual health and the metabolic syndrome in adolescents
Q28079375Metabolic Syndrome Increases the Risk for Knee Osteoarthritis: A Meta-Analysis
Q37370043Metabolic syndrome and cardiometabolic risk: an update
Q38948877Metabolic syndrome and dietary patterns: a systematic review and meta-analysis of observational studies.
Q34718421Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study.
Q37494304Metabolic syndrome and polycystic ovary syndrome... and vice versa
Q46622343Metabolic syndrome and selenium during gestation and lactation
Q50884222Metabolic syndrome and selenium in fetal programming: gender differences.
Q92782602Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review
Q35222459MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes
Q33519313Multivariate association analysis of the components of metabolic syndrome from the Framingham Heart Study
Q44508882Mutual associations among musculoskeletal diseases and metabolic syndrome components: A 3-year follow-up of the ROAD study
Q37149405Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment
Q38098935Novel risk factors for cardiovascular disease in rheumatoid arthritis
Q37219583Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes
Q51033492Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis.
Q37068805Perturbed autonomic nervous system function in metabolic syndrome
Q42396790Pharmacotherapy-Based Problems in the Management of Diabetes Mellitus: Needs Much More to be Done!
Q37687909Predicting of perceived self efficacy in the amount of macronutrients intake in women with metabolic syndrome - 2012.
Q33525176Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study
Q34461330Prevalence of the metabolic syndrome in a rural population in Ghana
Q37161301QTL-based association analyses reveal novel genes influencing pleiotropy of metabolic syndrome (MetS).
Q37248315Racial differences in risk of prostate cancer associated with metabolic syndrome
Q36948280Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Q24315816Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue
Q46687980Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: the Korea National Health and Nutrition Examination Survey (2007-2008).
Q84979204Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS)
Q39974616Retinal vascular caliber and metabolic syndrome in a Chinese population
Q92267523The association between serum uric acid level and changes of MRI findings in knee osteoarthritis: A retrospective study (A STROBE-compliant article)
Q51246246The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Q37235064The changing shape of type 2 diabetes
Q54280828The impact of high fructose on cardiovascular system: Role of α-lipoic acid.
Q36329919The metabolic syndrome: what's in a name?
Q24657961Traditional chinese medicine in treatment of metabolic syndrome
Q36982936Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience
Q49910023Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study
Q51372103Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome.
Q33651745Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort

Search more.